PharmTech Drug Digest 11.20
News|Articles|October 2, 2017

Pharmaceutical Technology

  • Pharmaceutical Technology-10-02-2017
  • Volume 41
  • Issue 10

Multi-Agitator System for Mixing and Dispersion Requirements

Ross, Charles & Son’s VersaMix is a multi-shaft mixer designed for viscous applications requiring a high level of accuracy and batch-to-batch consistency.

Ross, Charles & Son’s VersaMix is a multi-shaft mixer designed for viscous applications requiring a high level of accuracy and batch-to-batch consistency. The mixer consists of two or three independently-driven agitators working in tandem to ensure high-speed fine dispersion, efficient turnover, and uniform heating/cooling. 

The VMC-200 model has a maximum working capacity of 200 gallons. An air/oil lift raises and lowers the agitators into the vacuum-rated vessel. All product contact surfaces are stainless-steel type 316L polished 180-grit finish. The ASME 60-psi jacket on the vessel is insulated with two-inch thick mineral wool and sheathed with water-tight stainless-steel cladding.

Equipped with a 10HP anchor agitator, 20HP disperser, and 25HP rotor/stator, the mixer delivers a combination of laminar bulk flow and intensity necessary for homogenization and deagglomeration in high-viscosity conditions up to several hundred thousand centipoises. The vacuum cover includes multiple charging ports, viewing windows, tank light, and a thermoprobe. Finished product is discharged out of a three-inch pneumatically-actuated diaphragm valve installed on the tank’s conical bottom.

Available in standard sizes from 1- to 4000-gallon capacity, the mixer offers simple and reliable scalability from product development to full-scale production. Mixer features are tailored to a specific formulation or range of products for maximum functionality. 


Related to this article

Green Chemistry Supply and Demand in Sustainable Pharma
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.